Bioinformatics Market Report 2026

Bioinformatics Market Overview

• Bioinformatics market size has reached to $18.54 billion in 2025 • Expected to grow to $36.99 billion in 2030 at a compound annual growth rate (CAGR) of 14.7% • Growth Driver: Pharmaceutical Industry Growth Fuels The Bioinformatics Market • Market Trend: Applications Of Bioinformatics In Modern Science • North America was the largest region in 2025 and Western Europe is the fastest growing region.

What Is Covered Under Bioinformatics Market?

Bioinformatics, which is connected to genetics and genomics, uses computer technology to gather, store, analyze, and share biological information and data such as DNA and amino acid sequences or annotations about those sequences. The main product and service types of bioinformatics are knowledge management tools, data analysis platforms, and services. Knowledge management tools are technologies used by organizations to share information both internally and externally. The various applications include metabolomics, molecular phylogenetics, transcriptomics, proteomics, chemoinformatics, genomics, and others that are used by pharmaceutics, animal studies, agriculture, forensic science, and other end users.

What Is The Bioinformatics Market Growth Forecast?

The bioinformatics market size is expected to see rapid growth in the next few years. It will grow to $36.99 billion in 2030 at a compound annual growth rate (CAGR) of 14.7%. The growth in the forecast period can be attributed to increasing investments in precision medicine programs, rising adoption of ai-based biological data interpretation, expansion of population genomics studies, growing demand for scalable bioinformatics solutions, increased focus on data security and compliance. Major trends in the forecast period include increasing adoption of AI-driven genomic analysis tools, rising use of cloud-based bioinformatics platforms, growing integration of multi-omics data analysis, expansion of high-throughput data processing capabilities, enhanced focus on data interoperability and sharing.

Global Bioinformatics Market Segmentation

1) By Products and Services: Knowledge Management Tools, Data Analysis Platforms, Services 2) By Application: Metabolomics, Molecular Phylogenetics, Transcriptomics, Proteomics, Genomics 3) By End Users: Pharmaceutics, Animal Study, Agriculture Subsegments: 1) By Knowledge Management Tools: Data Integration Tools, Literature Mining Tools, Data Repositories And Databases, Biological Data Visualization Tools 2) By Data Analysis Platforms: Genomic Data Analysis Platforms, Proteomics Data Analysis Platforms, Transcriptomics Data Analysis Platforms, Metabolomics Data Analysis Platforms 3) By Services: Data Analysis Services, Consulting Services, Software And Platform-As-A-Service (PaaS), Bioinformatics Research And Development Services

What Is The Driver Of The Bioinformatics Market?

The growing pharmaceutical industry is expected to propel the growth of the bioinformatics market going forward. The pharmaceutical industry is a sector that involves the discovery, development, and production of drugs and medicines by both governmental and private entities. Bioinformatics is extensively used in the pharmaceutical industry to significantly accelerate the drug discovery and development processes, reduce costs, and improve the efficacy and safety of drug therapies. For instance, in November 2024, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based trade association, reported that in 2024 North America accounted for 54.8% of estimated world pharmaceutical sales compared with 22.7% for Europe. Therefore, the growing pharmaceutical industry is driving the growth of the bioinformatics industry.

Key Players In The Global Bioinformatics Market

Major companies operating in the bioinformatics market are Agilent Technologies Inc., Illumina Inc., QIAGEN NV, Affymetrix Inc., Thermo Fisher Scientific Inc., BGI Group, Dassault Systems SE, Bruker Corporation, Biomax Informatix AG, DNASTAR Inc., Partek Inc., Geneva Bioinformatics SA, Accelrys Inc., Nonlinear Dynamics SA, Sophia Genetics SA, Celera Corporation, Tripos Inc., IBM Life Sciences, GNS Healthcare Inc., DNAnexus Inc., Syapse Inc.

Global Bioinformatics Market Trends and Insights

Major companies in the bioinformatics market are focusing on developing technologically advanced solutions, such as bioinformatics platforms, to enhance data analysis capabilities, improve precision in personalized medicine, and accelerate drug discovery processes. A bioinformatics platform is a software system or integrated suite of tools designed to manage, analyze, and interpret biological data, such as genomic, proteomic, and metabolomic information, to support research and clinical decision-making. For instance, in February 2024, Metabolon, Inc., a US-based biotechnology company, launched an integrated bioinformatics platform. This platform offers a comprehensive suite of analytical tools designed to streamline metabolomics research, enabling users to conduct complex analyses with ease. Key features include advanced visualization tools like volcano plots and principal component analysis (PCA), as well as the innovative biomarker lenses, which provide targeted insights into specific pathways and diseases.

What Are Latest Mergers And Acquisitions In The Bioinformatics Market?

In October 2024, Certara, a US-based provider of model-informed drug development, biosimulation software, and scientific informatics solutions, acquired Chemaxon for US$ 90 million in cash. With this acquisition, Certara aims to enhance its in silico drug discovery and development capabilities by combining Chemaxon’s cheminformatics and bioinformatics tools with Certara’s biosimulation and AI-driven platforms. Chemaxon is a Hungary-based provider of cheminformatics and bioinformatics software, including molecular modeling, chemical data management, and compound design tools for life sciences research.

Regional Outlook

North America was the largest region in the bioinformatics market in 2025. Western Europe was the second largest region in the bioinformatics market analysis. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Bioinformatics Market?

The bioinformatics market includes revenues earned by entities by providing solutions which combine computer programming, information engineering, mathematics, and statistics to analyze biological data for drug discovery and preclinical studies. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Bioinformatics Market Report 2026?

The bioinformatics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the bioinformatics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.